X4P-001-103, A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients with WHIM Syndrome with Open-Label Extension
Study ID: STU-2019-1276
Summary
Please refer to the sections of the protocol titled [Quote]Study Design[Quote] and [Quote]STuDY oBJeCTiVeS anD enDPoinTS.[Quote]